Loading clinical trials...

High Flow Nasal Cannula for Safe Apnea | Clinical Trials | Clareo Health

COMPLETEDNA

High Flow Nasal Cannula for Safe Apnea

Effect of High-flow Nasal Oxygenation on Safe Apnea Time in Children With Open Mouth

NCT04849520•Seoul National University Hospital

Summary

This is a prospective randomized controlled trial comparing high flow nasal cannula and buccal oxygenation as method of oxygenation during apnea in children.

Detailed Description

This is a prospective randomized controlled trial comparing two oxygenation methods for prolongation of apnea time in children aged 0 to 10 years old. This study measures time for the pulse oximetry drop from 100% to 92% after oxygenation with 100% oxygen, applying high flow nasal cannula or buccal oxygen insufflation via an oral Ring-Adair-Elwyn endotracheal tube connected to oxygen.

Eligibility

Age

0 - 10 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Children under 11 years old undergoing general anesthesia with American Society of Anesthesiologists Physical Status 1 or 2.

Exclusion Criteria

•Refusal of enrollment from one or more legal guardians of the patient
•Plan of usage of supraglottic airway device as airway maintenance device
•Presence of upper respiratory tract infection of lung disease
•Premature infants younger than postconceptual age of 40 weeks
•Anticipation of difficult bag-mask ventilation due to facial anomaly or micrognathia
•Other conditions that are considered inappropriate for the study

Locations (1)

Seoul National University Hospital

Seoul, South Korea

Key Dates

Start Date

August 12, 2021

Primary Completion Date

March 21, 2023

Completion Date

March 21, 2023

Last Updated

July 28, 2023

Enrollment

ACTUAL participants

Conditions

Anesthesia, GeneralApnea

Interventions

High flow nasal cannula

DEVICE

Buccal oxygenation

DEVICE

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

NCT06430957

Obstructive Sleep Apnea Risk ManagementPostoperative Complications+2 more

View study

RECRUITINGNA

Digital-supported Orofacial Myofunctional Therapy in OSA

NCT07292922

Obstructive Sleep Apnea (OSA)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 28, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

High Flow Nasal Cannula for Safe Apnea

Inclusion Criteria

Exclusion Criteria

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

Digital-supported Orofacial Myofunctional Therapy in OSA

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

Maxillomandibular Advancement Surgery for Treatment of Obstructive Sleep Apnoea Syndrome

Spanish Registry of Patients With Sleep Apnea and Daytime Sleepiness

A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea